Seven innovation projects in AI and quantum technology receive grants from Knut and Alice Wallenberg Foundation

The Knut and Alice Wallenberg Foundation awarded seven Proof of Concept grants in AI and quantum technology, each sized between SEK 1–4 million for projects up to two years, to teams at Lund, Chalmers, KTH and Linköping to advance academic discoveries toward commercialization. Since 2017 the program has funded 128 grants, the Foundation has allocated just over SEK 39 billion historically (with ~SEK 2.4bn in 2024), the program is expanding to three calls per year and will include ICT next year; a second call for AI/quantum/ICT opens 19 Jan 2026 (deadline 25 Mar 2026).

Analysis

Market structure: These SEK 1–4m proof‑of‑concept grants (seven projects now; program expanded to three calls/year) primarily de‑risk early-stage Swedish AI/quantum research and raise demand for niche suppliers (chip‑scale photonics, 4K cryo amplifiers, foundry services). Winners are deep‑tech startups, specialised equipment vendors and European VC funds; losers are incumbents slow to adopt chip‑scale approaches and generic outsourcing services. Cross‑asset: expect modest positive skew for long‑dated tech equities and SEK appreciation on successful commercialization signals; fixed income spreads for small Swedish tech firms should compress if follow‑on capital flows materialize.

Risk assessment: Tail risks include stricter AI healthcare regulation (CE/EMA) and export controls on quantum hardware, or technical dead‑ends (50%+ failure rate typical for PoC). Immediate impact is negligible; short‑term (3–12 months) is increased deal flow and demo news; long‑term (2–7 years) is potential spinouts, M&A or partner deals. Hidden dependencies: foundry/cryogenics bottlenecks and skilled talent supply; catalysts are spinout announcements, industrial partnerships, and the next WALP call (opens 19 Jan 2026, deadline 25 Mar 2026).

Trade implications: For public markets, overweight specialist suppliers to photonics/cryogenics and optionality on quantum hardware while keeping sizes small (1–3% positions). Use 9–18 month call spreads on NVDA/ASML for AI compute and lithography exposure and 18‑month LEAPS on IONQ (or other public quantum names) for asymmetric upside. Rotate +1–3% from broad cyclicals into medtech AI and semiconductor equipment over next 6–12 months, scaling into spinout validation events.

Contrarian angles: Consensus underestimates the program’s multiplier effect — small grants plus WALP coaching historically convert to higher‑value spinouts (128 grants since 2017). Conversely, the market may be overstating near‑term commercialization; many projects won’t produce revenue for 3–7 years, creating mispricings in small suppliers and VC exposure. Historical parallel: early DARPA/NIST funding created multi‑decade winners but required patient capital; unintended consequences include talent drain and valuation froth that could reverse on a high‑profile technical failure.

Key Decisions for Investors

• Establish a 1–2% overweight long position in ASML (ASML) or Applied Materials (AMAT) split 60/40 to capture chip‑scale photonics lithography demand; scale in over 3 months and take profits at +25% or if order intake misses for two quarters.
• Allocate 0.5–1.0% to quantum hardware optionality via IonQ (IONQ) LEAPS (18‑month calls) sized so max loss = stated allocation; increase to 2% if a Wallenberg‑backed spinout secures >SEK 20m Series A or announces an industrial partner within 12 months.
• Buy 9–12 month call spreads (0.5–1% notional) on NVIDIA (NVDA) to hedge for uplift in AI compute demand from new academic spinouts; target payoff if NVDA rises >15% in 6–12 months, cap cost by selling higher strike.
• Reduce exposure to Europe small‑cap medtech/diagnostics by 1–2% and redeploy into specialized photonics/equipment names; threshold: cut remaining position to zero if regulatory inspection/actions occur on AI diagnostic tools in EU within next 6 months.
• Monitor WALP spinouts and Wallenberg Proof‑of‑Concept announcements through 25 Mar 2026; if two or more projects announce commercial partnerships or >SEK 50m total follow‑on funding within 6 months, increase European deep‑tech VC/private allocation by +2–3%.